financetom
Business
financetom
/
Business
/
South Pacific Metals Up 1.5% As Obtains Injunction to Protect Exclusive Rights on EL2558 Licence Area
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
South Pacific Metals Up 1.5% As Obtains Injunction to Protect Exclusive Rights on EL2558 Licence Area
Aug 14, 2025 11:59 AM

02:31 PM EDT, 08/14/2025 (MT Newswires) -- South Pacific Metals ( SPMEF ) was edging higher Thursday after saying its subsidiary Kainantu Resources, has obtained an interim injunction from the Papua New Guinea national court restraining K92 Mining ( KNTNF ) from "interfering with or contravening" Kainantu's exclusive exploration rights within its EL 2558 licence area.

A statement noted the action was undertaken following what South Pacific perceived to be K92 trespassing on the property. According to the statement, EL 2558 borders K92's active drilling and gold producing operations to the northeast.

South Pacific has also filed for declaratory relief to confirm that Kainantu Resources is the exclusive registered holder of the licence, and that it alone holds surface and subsurface mineral exploration rights within the licence boundaries.

The matter will return to court on Aug. 22.

South Pacific is up $0.01, to $0.69, on the TSX Venture Exchange. K92 was down 1.5% to near $14.70, on the Toronto Stock Exchange.

Price: 0.69, Change: +0.01, Percent Change: +1.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved